Initiating treatment of chronic obstructive pulmonary disease (COPD) with a long acting β2 agonist or a long acting antimuscarinic antagonist is associated with a 50% higher risk of serious...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2CvEfDI
via
IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου